NetLine has unveiled HQL Access, a groundbreaking solution empowering GTM teams with first-party buyer intelligence earlier than ever. By providing unmatched visibility into high-quality leads (HQLs) ...
I maintain a buy rating on abrdn Life Sciences Investors Fund (HQL), which trades at an 8.49% discount to NAV and offers a 12.6% yield. HQL is positioned to benefit from the accelerating GLP-1 market, ...
HQL offers a high 12% yield and trades at a discount, making it attractive for income-focused investors seeking healthcare sector exposure. The fund is heavily weighted in biotechnology, leading to ...
CAMPBELL, CALIFORNIA / ACCESS Newswire / May 7, 2025 / NetLine, the #1 Programmatic B2B Lead Generation Platform, announced the launch of HQL Precision today - a new product built to give marketers ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Tekla Life Sciences Investors said on August 15, 2023 that its board of directors declared a regular quarterly dividend of $0.32 per share ($1.28 annualized). Previously, the company paid $0.32 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results